Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?

Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Hepatology Wolters Kluwer Health

Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?

Hepatology , Volume 54 (4) – Oct 1, 2011

Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?

Loading next page...
 
/lp/wolters-kluwer-health/will-the-increased-prevalence-of-nonalcoholic-steatohepatitis-nash-in-snn80LO3tV

References (18)

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2011 American Association for the Study of Liver Diseases
ISSN
0270-9139
eISSN
1527-3350
DOI
10.1002/hep.24634
pmid
21956705
Publisher site
See Article on Publisher Site

Abstract

Journal

HepatologyWolters Kluwer Health

Published: Oct 1, 2011

There are no references for this article.